Real-World Determinants of Olanzapine Prescribing for Antiemetic Prophylaxis in Adults Receiving Highly-Emetogenic Chemotherapy. [PDF]
Fariman S +4 more
europepmc +1 more source
Does Adjuvant Metformin Reduce Olanzapine-Induced Metabolic Adverse Effects in Patients Diagnosed With Schizophrenia. [PDF]
Butt A, Sadiq S.
europepmc +1 more source
Akkermansia muciniphila Alleviates Olanzapine-Induced Hepatic Steatosis via the Gut Microbiota-IGFBP2/APOA1-Liver Axis. [PDF]
Wang J +7 more
europepmc +1 more source
Adjuvant Mood Stabilisers for Long-Term Management of Treatment-Resistant Schizophrenia: A Case Report. [PDF]
Anyameluhor F, Elliott C.
europepmc +1 more source
Association of Atypical Antipsychotics With Lipid Abnormalities in Adult Patients With Schizophrenia: A Scoping Review. [PDF]
Abavana V, Sadiq S.
europepmc +1 more source
Association of Peripheral Inflammatory Indices With Symptom Severity, Functioning, and Metabolic Parameters in the Mexican Population Diagnosed With Schizophrenia. [PDF]
Guzmán-González H +3 more
europepmc +1 more source
Prevalence and predictors of high-dose antipsychotic therapy among adult psychiatric inpatients in Baghdad, Iraq. [PDF]
Nassr OA, Wadeea RF.
europepmc +1 more source
Efficacy of Different Combination Therapies for Mania in Bipolar Disorder: A Systematic Review and Meta-Analysis. [PDF]
Yao P, Ni P, Yin L.
europepmc +1 more source
Trends in use of antipsychotics in Germany 2014-2024: a nationwide population-based study. [PDF]
Espinosa Daudí A, Kieble M, Schulz M.
europepmc +1 more source
International Survey for Antiemetics in Hematopoietic Stem Cell Transplantation in the APBMT Centers. [PDF]
Yakushijin K +31 more
europepmc +1 more source

